SymbioTex

📍 Wolverhampton, United Kingdom🗓 Founded 2021👥 2 employees💰 Last funded Jul 2023
Biotechnology Research🌐 symbio-tex.com
Website LinkedIn
We produce rigid seaweed-derived bioplastics. Products made of our patent pending material are home compostable and therefore naturally degrade back into nature in a harmless way. We are on a mission to make the medical sector more sustainable by producing home compostable medical devices (such as inhalers and pregnancy tests). We don’t use any harmful chemicals in manufacturing nor does our material compete with food crops.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in SymbioTex?
SymbioTex has 1 investors on record on gritt.io, including 1 early-stage backers.
When did SymbioTex last raise funding?
The most recent investment in SymbioTex recorded on gritt.io was in July 2023.
When was SymbioTex founded?
SymbioTex was founded in 2021.
What industry is SymbioTex in?
SymbioTex operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SymbioTex based?
SymbioTex is headquartered in Wolverhampton, United Kingdom.